Analysts expect Eton Pharmaceuticals, Inc. to report revenue of 44.24 M for Q3 26, against a range of 42.81 M to 45.66 M. The most recent reported quarter, Q2 26, came in at 37.59 M, a 34.2% beat against the 28.00 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 10.32 M | 11.65 M | 17.28 M | 18.93 M | 22.46 M | 21.28 M | 24.27 M | 37.59 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 9.89 M | 12.14 M | 17.11 M | 18.21 M | 22.01 M | 22.00 M | 23.84 M | 30.15 M | 45.66 M | 50.61 M | 58.14 M | 59.34 M | 76.31 M | 79.43 M | 68.83 M | 69.61 M | ||||||||||
| Low Estimate | 8.67 M | 10.33 M | 14.81 M | 16.03 M | 20.54 M | 19.81 M | 19.72 M | 25.86 M | 42.81 M | 43.62 M | 48.25 M | 53.93 M | 65.34 M | 72.80 M | 60.38 M | 60.17 M | ||||||||||
| Consensus Estimate | 9.28 M | 11.24 M | 15.96 M | 17.12 M | 21.28 M | 20.90 M | 21.78 M | 28.00 M | 44.24 M | 47.11 M | 53.19 M | 56.63 M | 70.83 M | 76.11 M | 64.61 M | 64.89 M |
Analysts expect Eton Pharmaceuticals, Inc. to report earnings per share of 0.32 for Q3 26, against a range of 0.30 to 0.34. The most recent reported quarter, Q2 26, came in at 0.35, a 75.0% beat against the 0.20 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.02 | -0.02 | -0.06 | -0.10 | 0.04 | 0.17 | 0.14 | 0.35 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.01 | 0.00 | 0.05 | -0.04 | 0.08 | 0.15 | 0.12 | 0.21 | 0.34 | 0.38 | 0.41 | 0.43 | 0.56 | 0.57 | 0.78 | 0.78 | ||||||||||
| Low Estimate | -0.01 | 0.00 | 0.05 | -0.04 | 0.08 | 0.13 | 0.10 | 0.19 | 0.30 | 0.32 | 0.37 | 0.41 | 0.48 | 0.53 | 0.70 | 0.68 | ||||||||||
| Consensus Estimate | -0.01 | 0.00 | 0.05 | -0.04 | 0.08 | 0.14 | 0.11 | 0.20 | 0.32 | 0.35 | 0.39 | 0.42 | 0.52 | 0.55 | 0.74 | 0.73 |
Pull Wall Street consensus for Eton Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ETON&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ETON", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ETON&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();